Leukemia & Lymphoma, Volume 61, Issue 10 (2020)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Leukemia & Lymphoma, Volume 61, Issue 10 (2020)

See all volumes and issues
Vol 65, 2024 Vol 64, 2023 Vol 63, 2022 Vol 62, 2021 Volume 61, 2020 Vol 60, 2019 Vol 59, 2018 Vol 58, 2017 Vol 57, 2016 Vol 56, 2015 Vol 55, 2014 Vol 54, 2013 Vol 53, 2012 Vol 52, 2011 Vol 51, 2010 Vol 50, 2009 Vol 49, 2008 Vol 48, 2007 Vol 47, 2006 Vol 46, 2005 Vol 45, 2004 Vol 44, 2003 Vol 43, 2002 Vol 42, 2001 Vol 41, 2001 Vol 40, 2000-2001 Vol 39, 2000 Vol 38, 2000 Vol 37, 2000 Vol 36, 1999-2000 Vol 35, 1999 Vol 34, 1999 Vol 33, 1999 Vol 32, 1998-1999 Vol 31, 1998 Vol 30, 1998 Vol 29, 1998 Vol 28, 1997-1998 Vol 27, 1997 Vol 26, 1997 Vol 25, 1997 Vol 24, 1996-1997 Vol 23, 1996 Vol 22, 1996 Vol 21, 1996 Vol 20, 1995-1996 Vol 19, 1995 Vol 18, 1995 Vol 17, 1995 Vol 16, 1995 Vol 15, 1995 Vol 16, 1995 Vol 15, 1995 Vol 14, 1994 Vol 13, 1994 Vol 12, 1993-1994 Vol 11, 1993 Vol 10, 1993 Vol 9, 1993 Vol 8, 1992 Vol 7, 1992 Vol 6, 1991-1992 Vol 5, 1991 Vol 4, 1991 Vol 3, 1990-1991 Vol 2, 1990 Vol 1, 1989-1990
Download citations Download PDFs

Commentaries

Immune impacts of Bruton tyrosine kinase inhibitors in chronic lymphocytic leukemia patients: are we closer to a holy grail?
Sasanka M. Handunnetti & Constantine S. Tam
Pages: 2283-2285
Published online: 08 Sep 2020
First Page PreviewforImmune impacts of Bruton tyrosine kinase inhibitors in chronic lymphocytic leukemia patients: are we closer to a holy grail? | Full Text | References | PDF (526.9 KB) | EPUB
  • 178 Views
  • 0 CrossRef citations
  • 0Altmetric
Tumor lysis syndrome: still the Achilles heel of venetoclax in treatment of CLL?
Mary Ann Anderson & John Francis Seymour
Pages: 2286-2288
Published online: 04 Aug 2020
First Page PreviewforTumor lysis syndrome: still the Achilles heel of venetoclax in treatment of CLL? | Full Text | References | PDF (304.8 KB) | EPUB
  • 229 Views
  • 2 CrossRef citations
  • 0Altmetric
Increasing megakaryopoiesis without promoting the malignant clone in myeloid malignancies
Alain Mina & Leonidas C. Platanias
Pages: 2289-2291
Published online: 11 Aug 2020
First Page PreviewforIncreasing megakaryopoiesis without promoting the malignant clone in myeloid malignancies | Full Text | References | PDF (303.2 KB) | EPUB
  • 76 Views
  • 0 CrossRef citations
  • 0Altmetric
Ibrutinib and invasive fungal infections: the known, the unknown and the known unknowns
Gemma Reynolds, Monica Slavin & Benjamin W. Teh
Pages: 2292-2294
Published online: 23 Jul 2020
First Page PreviewforIbrutinib and invasive fungal infections: the known, the unknown and the known unknowns | Full Text | References | PDF (513.9 KB) | EPUB
  • 275 Views
  • 5 CrossRef citations
  • 0Altmetric

Reviews

Review
Following in the footsteps of acute myeloid leukemia: are we witnessing the start of a therapeutic revolution for higher-risk myelodysplastic syndromes?
Jan Philipp Bewersdorf & Amer M. Zeidan
Pages: 2295-2312
Published online: 18 May 2020
AbstractforFollowing in the footsteps of acute myeloid leukemia: are we witnessing the start of a therapeutic revolution for higher-risk myelodysplastic syndromes? | Full Text | References | PDF (1.4 MB) | EPUB
  • 584 Views
  • 7 CrossRef citations
  • 0Altmetric
Review
Follicular lymphoma genomics
Lucy Pickard, Giuseppe Palladino & Jessica Okosun
Pages: 2313-2323
Published online: 19 May 2020
AbstractforFollicular lymphoma genomics | Full Text | References | PDF (1.3 MB) | EPUB
  • 798 Views
  • 6 CrossRef citations
  • 0Altmetric
Review
Dissecting factors influencing response to CAR T cell therapy in B lymphoid hematologic malignancies: from basic to practice
Kitsada Wudhikarn & Jae H. Park
Pages: 2324-2334
Published online: 10 Jun 2020
AbstractforDissecting factors influencing response to CAR T cell therapy in B lymphoid hematologic malignancies: from basic to practice | Full Text | References | PDF (1.1 MB) | EPUB
  • 564 Views
  • 6 CrossRef citations
  • 0Altmetric

Emerging Drug Profile

Article
Selinexor for advanced hematologic malignancies
Janek S. Walker, Ramiro Garzon & Rosa Lapalombella
Pages: 2335-2350
Published online: 14 Jun 2020
AbstractforSelinexor for advanced hematologic malignancies | Full Text | References | PDF (1.7 MB) | EPUB
  • 1312 Views
  • 11 CrossRef citations
  • 0Altmetric

Original Articles

Article
The paradoxical prognostic role of 1q21 Gain/Amplification in multiple myeloma: every coin has two sides
Jiadai Xu, Tianhong Xu, Yang Yang, Wenjing Wang, Jing Li, Yuhong Ren, Shiyang Gu, Chen Chen, Zheng Wei, Jingli Zhuang, Zhimei Wang, Lili Ji, Luya Cheng, Weiguang Wang, Zhixiang Cheng, Yang Ke, Ling Yuan & Peng Liu
Pages: 2351-2364
Published online: 10 Jun 2020
AbstractforThe paradoxical prognostic role of 1q21 Gain/Amplification in multiple myeloma: every coin has two sides | Full Text | References | PDF (3.3 MB) | EPUB | Supplemental
  • 301 Views
  • 9 CrossRef citations
  • 0Altmetric
Article
Autologous stem cell transplantation in multiple myeloma patients: utilization patterns and hospital effects
Lina Jansen, Maximilian Merz, Monika Engelhardt, Katja Weisel, Christof Scheid, Christian Straka, Christian Langer, Hans Salwender, Hermann Einsele, Nikolaus Kröger, Dietrich W. Beelen, Peter Dreger, Hartmut Goldschmidt, Hermann Brenner & the German National Registry for Stem Cell Transplants (DRST)
Pages: 2365-2374
Published online: 30 May 2020
AbstractforAutologous stem cell transplantation in multiple myeloma patients: utilization patterns and hospital effects | Full Text | References | PDF (1.3 MB) | EPUB | Supplemental
  • 176 Views
  • 3 CrossRef citations
  • 0Altmetric
Article
Reconstitution of humoral immunity and decreased risk of infections in patients with chronic lymphocytic leukemia treated with Bruton tyrosine kinase inhibitors
Christopher Pleyer, Clare Sun, Sanjal Desai, Inhye E. Ahn, Xin Tian, Pia Nierman, Susan Soto, Jeanine Superata, Janet Valdez, Jennifer Lotter & Adrian Wiestner
Pages: 2375-2382
Published online: 06 Jun 2020
AbstractforReconstitution of humoral immunity and decreased risk of infections in patients with chronic lymphocytic leukemia treated with Bruton tyrosine kinase inhibitors | Full Text | References | PDF (1.3 MB) | EPUB
  • 722 Views
  • 12 CrossRef citations
  • 0Altmetric
Article
Incidence and risk of tumor lysis syndrome in patients with relapsed chronic lymphocytic leukemia (CLL) treated with venetoclax in routine clinical practice
Amber B. Koehler, Nelson Leung, Timothy G. Call, Kari G. Rabe, Sara J. Achenbach, Wei Ding, Saad S. Kenderian, Jose F. Leis, Yucai Wang, Eli Muchtar, Suzanne R. Hayman, Paul J. Hampel, Heidi D. Finnes, Susan M. Schwager, Susan L. Slager, Neil E. Kay & Sameer A. Parikh
Pages: 2383-2388
Published online: 25 May 2020
AbstractforIncidence and risk of tumor lysis syndrome in patients with relapsed chronic lymphocytic leukemia (CLL) treated with venetoclax in routine clinical practice | Full Text | References | PDF (914.7 KB) | EPUB
  • 611 Views
  • 11 CrossRef citations
  • 0Altmetric
Article
Combination of multicolor flow cytometry for circulating lymphoma cells and tests for the RHOAG17V and IDH2R172 hot-spot mutations in plasma cell-free DNA as liquid biopsy for the diagnosis of angioimmunoblastic T-cell lymphoma
Masahiko Hayashida, Fumiyo Maekawa, Yoshinari Chagi, Futoshi Iioka, Yoichiro Kobashi, Mikio Watanabe & Hitoshi Ohno
Pages: 2389-2398
Published online: 30 May 2020
AbstractforCombination of multicolor flow cytometry for circulating lymphoma cells and tests for the RHOAG17V and IDH2R172 hot-spot mutations in plasma cell-free DNA as liquid biopsy for the diagnosis of angioimmunoblastic T-cell lymphoma | Full Text | References | PDF (1.9 MB) | EPUB | Supplemental
  • 278 Views
  • 9 CrossRef citations
  • 0Altmetric
Article
Novel tumor-targeted liposomes comprised of an MDM2 antagonist plus proteasome inhibitor display anti-tumor activity in a xenograft model of bortezomib-resistant Waldenstrom macroglobulinemia
Vijay Sagar Madamsetty, Aneel Paulus, Sharoon Akhtar, Alak Manna, Harikrishna Reddy Rachamalla, RajKumar Banerjee, Debabrata Mukhopadhyay & Asher Chanan-Khan
Pages: 2399-2408
Published online: 19 Jun 2020
AbstractforNovel tumor-targeted liposomes comprised of an MDM2 antagonist plus proteasome inhibitor display anti-tumor activity in a xenograft model of bortezomib-resistant Waldenstrom macroglobulinemia | Full Text | References | PDF (3.2 MB) | EPUB | Supplemental
  • 213 Views
  • 5 CrossRef citations
  • 0Altmetric
Article
The effect of ibrutinib on neutrophil and γδ T cell functions
Denise Risnik, Esteban E. Elías, Irene Keitelman, Ana Colado, Enrique Podaza, Gregorio Cordini, Maricef Vergara Rubio, Horacio Fernández Grecco, Raimundo Fernando Bezares, Mercedes Borge, Analía Trevani, Mirta Giordano, Carolina Jancic & Romina Gamberale
Pages: 2409-2418
Published online: 19 Apr 2020
AbstractforThe effect of ibrutinib on neutrophil and γδ T cell functions | Full Text | References | PDF (1.4 MB) | EPUB | Supplemental
  • 582 Views
  • 13 CrossRef citations
  • 0Altmetric
Article
Early evidence of pulmonary dysfunction in survivors of childhood Hodgkin lymphoma
Jennifer E. Agrusa, Viral D. Kothari, Austin L. Brown, Prakash M. Masand, Gary D. Lewis, Bin S. Teh, Arnold C. Paulino, Manuel D. Silva-Carmona, Ernestina Melicoff, Carl E. Allen & Monica M. Gramatges
Pages: 2419-2427
Published online: 10 Jun 2020
AbstractforEarly evidence of pulmonary dysfunction in survivors of childhood Hodgkin lymphoma | Full Text | References | PDF (1.8 MB) | EPUB | Supplemental
  • 135 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
Long-term outcomes of patients with unfavorable stage I–II classic Hodgkin lymphoma treated with Stanford V chemotherapy and limited field irradiation
Christopher R. Weil, Yushen Qian, Rie Von Eyben, Sarah E. Daadi, Karen S. Corbelli, Saul A. Rosenberg, Ranjana H. Advani & Richard T. Hoppe
Pages: 2428-2434
Published online: 30 May 2020
AbstractforLong-term outcomes of patients with unfavorable stage I–II classic Hodgkin lymphoma treated with Stanford V chemotherapy and limited field irradiation | Full Text | References | PDF (792.7 KB) | EPUB | Supplemental
  • 174 Views
  • 3 CrossRef citations
  • 0Altmetric
Article
Primary prophylaxis with pegfilgrastim in patients with newly-diagnosed diffuse large B-cell lymphoma: propensity score and instrumental variable analyses
Kensuke Matsuda, Jo Taisuke, Masashi Miyauchi, Kazuhiro Toyama, Kumi Nakazaki, Hiroki Matsui, Kiyohide Fushimi, Hideo Yasunaga & Mineo Kurokawa
Pages: 2435-2441
Published online: 12 Jun 2020
AbstractforPrimary prophylaxis with pegfilgrastim in patients with newly-diagnosed diffuse large B-cell lymphoma: propensity score and instrumental variable analyses | Full Text | References | PDF (562.3 KB) | EPUB
  • 553 Views
  • 6 CrossRef citations
  • 0Altmetric
Article
Potential impact of consolidation radiation therapy for advanced Hodgkin lymphoma: a secondary analysis of SWOG S0816
Chul S. Ha, Michael LeBlanc, Heiko Schöder, Chelsea C. Pinnix, Nancy L. Bartlett, Andrew M. Evens, Eric D. Hsi, Lisa Rimsza, Michael V. Knopp, Jun Zhang, John P. Leonard, Brad S. Kahl, Hongli Li, Sonali Smith, Louis S. Constine & Jonathan W. Friedberg
Pages: 2442-2447
Published online: 26 May 2020
AbstractforPotential impact of consolidation radiation therapy for advanced Hodgkin lymphoma: a secondary analysis of SWOG S0816 | Full Text | References | PDF (779 KB) | EPUB
  • 245 Views
  • 1 CrossRef citations
  • 0Altmetric
Article
Optimal oral cyclosporin dosing with concomitant posaconazole post allogeneic stem cell transplantation
Danielle H. Robinson, Charlotte F. M. Hughes & Andrew Grigg
Pages: 2448-2452
Published online: 30 May 2020
AbstractforOptimal oral cyclosporin dosing with concomitant posaconazole post allogeneic stem cell transplantation | Full Text | References | PDF (536.7 KB) | EPUB
  • 253 Views
  • 3 CrossRef citations
  • 0Altmetric
Article
The thrombopoietin mimetic JNJ-26366821 increases megakaryopoiesis without affecting malignant myeloid proliferation
Diego Adrianzen-Herrera, Gaurav Choudhary, Shanisha Gordon-Mitchell, Nandini Ramachandra, Tushar Bhagat, Hui Zhang, Srinivas Aluri, Aditi Shastri, Ulrich Steidl, Britta Will, Weng-Lang Yang, Michelle Mahler, Gary Eichenbaum, Chandan Guha & Amit Verma
Pages: 2453-2465
Published online: 24 Jun 2020
AbstractforThe thrombopoietin mimetic JNJ-26366821 increases megakaryopoiesis without affecting malignant myeloid proliferation | Full Text | References | PDF (3.4 MB) | EPUB
  • 1656 Views
  • 1 CrossRef citations
  • 0Altmetric
Open Access
Article
Fc gamma receptor expression serves as prognostic and diagnostic factor in AML
Jonas S. Heitmann, Ilona Hagelstein, Clemens Hinterleitner, Lukas Osburg, Helmut R. Salih, Joseph Kauer & Melanie Märklin
Pages: 2466-2474
Published online: 16 Jun 2020
AbstractforFc gamma receptor expression serves as prognostic and diagnostic factor in AML | Full Text | References | PDF (2.3 MB) | EPUB | Supplemental
  • 352 Views
  • 6 CrossRef citations
  • 0Altmetric
Article
MicroRNA-92a as a marker of treatment response and survival in adult acute myeloid leukemia patients
Reham A. Rashed, Naglaa M. Hassan & Marwa M. Hussein
Pages: 2475-2481
Published online: 14 Jun 2020
AbstractforMicroRNA-92a as a marker of treatment response and survival in adult acute myeloid leukemia patients | Full Text | References | PDF (810.4 KB) | EPUB
  • 91 Views
  • 2 CrossRef citations
  • 0Altmetric
Article
The prognostic value of CD2, CD4, and HLA-DR expression and FLT3-ITD mutation in adult acute promyelocytic leukemia
Lu Nie, Rongjun Ma, Xiaoli Yuan, Li Jiang, Shiwei Yang, Hui Xu, Xiaoyin Liu, Yuanbo Liu, Lin Zhang & Zunmin Zhu
Pages: 2482-2487
Published online: 30 May 2020
AbstractforThe prognostic value of CD2, CD4, and HLA-DR expression and FLT3-ITD mutation in adult acute promyelocytic leukemia | Full Text | References | PDF (991.2 KB) | EPUB
  • 252 Views
  • 3 CrossRef citations
  • 0Altmetric

Letters to the Editor

Letter
Incidence and characterization of fungal infections in chronic lymphocytic leukemia patients receiving ibrutinib
Michael Frei, Samuel L. Aitken, Nitin Jain, Philip Thompson, William Wierda, Dimitrios P. Kontoyiannis & Adam J. DiPippo
Pages: 2488-2491
Published online: 12 Jun 2020
First Page PreviewforIncidence and characterization of fungal infections in chronic lymphocytic leukemia patients receiving ibrutinib | Full Text | References | PDF (564.2 KB) | EPUB | Supplemental
  • 603 Views
  • 18 CrossRef citations
  • 0Altmetric
Letter
Characteristics and outcomes of patients with relapsed follicular lymphoma following retreatment with second-line rituximab-containing chemotherapy
Jiajia Liu, Douglas Stewart, Amelie Fontaine, Anthea Peters, Isabelle Fleury, Luigina Mollica, Anca Prica, Rena Buckstein, Laurie Sehn, Aixiang Jiang, John Kuruvilla & Diego Villa
Pages: 2492-2496
Published online: 10 Jun 2020
First Page PreviewforCharacteristics and outcomes of patients with relapsed follicular lymphoma following retreatment with second-line rituximab-containing chemotherapy | Full Text | References | PDF (957.1 KB) | EPUB | Supplemental
  • 285 Views
  • 0 CrossRef citations
  • 0Altmetric
Letter
Hypofibrinogenemia and disseminated intravascular coagulation rarely complicate treatment-naïve acute lymphoblastic leukemia
Charles Gaulin, Angela Chan, Andriy Derkach, Jae H. Park, Simon Mantha, Mark B. Geyer & Martin S. Tallman
Pages: 2497-2501
Published online: 18 May 2020
First Page PreviewforHypofibrinogenemia and disseminated intravascular coagulation rarely complicate treatment-naïve acute lymphoblastic leukemia | Full Text | References | PDF (669.3 KB) | EPUB
  • 230 Views
  • 1 CrossRef citations
  • 0Altmetric
Letter
New tricks for old drugs: combination of rituximab and two nanoparticle-delivered chemotherapy drugs, albumin-bound paclitaxel and pegylated liposomal doxorubicin, in the treatment of relapsed/refractory diffuse large B cell lymphoma
Liang Wang, Xiao-qin Chen & Zhong-jun Xia
Pages: 2502-2506
Published online: 06 Jun 2020
First Page PreviewforNew tricks for old drugs: combination of rituximab and two nanoparticle-delivered chemotherapy drugs, albumin-bound paclitaxel and pegylated liposomal doxorubicin, in the treatment of relapsed/refractory diffuse large B cell lymphoma | Full Text | References | PDF (839.4 KB) | EPUB
  • 243 Views
  • 3 CrossRef citations
  • 0Altmetric
Letter
Treatment disparities in minority groups with multiple myeloma at a safety-net hospital
Michael Dennis, Asaf Maoz, Diana Cirstea, Ami Patel, Adam Lerner & Shayna Sarosiek
Pages: 2507-2510
Published online: 27 May 2020
First Page PreviewforTreatment disparities in minority groups with multiple myeloma at a safety-net hospital | Full Text | References | PDF (566.6 KB) | EPUB | Supplemental
  • 170 Views
  • 3 CrossRef citations
  • 0Altmetric
Letter
Case series of chronic myeloid leukemia patients who maintained deep molecular response (DMR) with very low-dose ponatinib: experience in discontinuing low-dose ponatinib and treatment-free remission (TFR) outcomes
Jonathan Cohen, Alison Palumbo, Jason Wing & Michael C. Heinrich
Pages: 2511-2514
Published online: 26 May 2020
First Page PreviewforCase series of chronic myeloid leukemia patients who maintained deep molecular response (DMR) with very low-dose ponatinib: experience in discontinuing low-dose ponatinib and treatment-free remission (TFR) outcomes | Full Text | References | PDF (470.7 KB) | EPUB
  • 223 Views
  • 1 CrossRef citations
  • 0Altmetric
Letter
Chronic myelogenous leukemia presenting as central retinal vein occlusion
Marianne Cote-Olijnyk, Sabrina Fowlkes & Sarit Assouline
Pages: 2515-2518
Published online: 22 Jun 2020
First Page PreviewforChronic myelogenous leukemia presenting as central retinal vein occlusion | Full Text | References | PDF (595.3 KB) | EPUB
  • 118 Views
  • 0 CrossRef citations
  • 0Altmetric
Letter
Impact of anti-CD38 therapy in multiple myeloma with high-risk cytogenetics: systematic review and meta-analysis
Ghulam Rehman Mohyuddin, Monia Sigle, Viveksandeep Thoguluva Chandrasekar, Muhammad Aziz, Al-Ola Abdallah, Leyla Shune & Brian McClune
Pages: 2519-2522
Published online: 06 Jun 2020
First Page PreviewforImpact of anti-CD38 therapy in multiple myeloma with high-risk cytogenetics: systematic review and meta-analysis | Full Text | References | PDF (628.3 KB) | EPUB | Supplemental
  • 628 Views
  • 7 CrossRef citations
  • 0Altmetric
Letter
Three monocytic neoplasms in a single patient
María Angeles Pérez-Sáenz, Socorro Maria Rodriguez-Pinilla, Rocío N. Salgado, Nerea Carvajal, Cristina Serrano, Carlos Soto, Juana Serrano, Mireia Atance, José Luis López-Lorenzo, Luis Requena, Federico Rojo, Miguel Angel Piris, Pilar Llamas & Juan Manuel Alonso-Dominguez
Pages: 2523-2526
Published online: 25 May 2020
First Page PreviewforThree monocytic neoplasms in a single patient | Full Text | References | PDF (555.7 KB) | EPUB
  • 97 Views
  • 2 CrossRef citations
  • 0Altmetric
Letter
Clinical utility of genomic DNA Q-PCR for the monitoring of a patient with atypical e19a2 BCR-ABL1 transcripts in chronic myeloid leukemia
Ilaria S. Pagani, Phuong Dang, Verity A. Saunders, Jodi Braley, Angelica Thieleke, Susan Branford, Timothy P. Hughes & David M. Ross
Pages: 2527-2529
Published online: 06 Jun 2020
First Page PreviewforClinical utility of genomic DNA Q-PCR for the monitoring of a patient with atypical e19a2 BCR-ABL1 transcripts in chronic myeloid leukemia | Full Text | References | PDF (989.2 KB) | EPUB
  • 177 Views
  • 5 CrossRef citations
  • 0Altmetric
Letter
Management of erroneous subcutaneous injection of vincristine
Diego de Goycoechea, Natacha Dewarrat, Laura E. Rothuizen, Maurice Matter, Monika Nagy, Gisèle Locher, Olivier Spertini & Sabine Blum
Pages: 2530-2532
Published online: 06 Jun 2020
First Page PreviewforManagement of erroneous subcutaneous injection of vincristine | Full Text | References | PDF (1.2 MB) | EPUB
  • 171 Views
  • 2 CrossRef citations
  • 0Altmetric
Letter
Pegylated interferon can control myelodysplastic/myeloproliferative syndrome with ring sideroblasts and thrombocytosis
Rudolf Benz, Kathrin Zimmermann, Markus Rechsteiner, Stefan Balabanov, Markus G. Manz & Corinne C. Widmer
Pages: 2533-2535
Published online: 25 May 2020
First Page PreviewforPegylated interferon can control myelodysplastic/myeloproliferative syndrome with ring sideroblasts and thrombocytosis | Full Text | References | PDF (622 KB) | EPUB
  • 139 Views
  • 0 CrossRef citations
  • 0Altmetric
Letter
Continuous high-dose ivermectin appears to be safe in patients with acute myelogenous leukemia and could inform clinical repurposing for COVID-19 infection
Claudio Galvao de Castro Jr.Lauro Jose Gregianin & Jan A. Burger
Pages: 2536-2537
Published online: 01 Jul 2020
CitationforContinuous high-dose ivermectin appears to be safe in patients with acute myelogenous leukemia and could inform clinical repurposing for COVID-19 infection | Full Text | References | PDF (512.5 KB) | EPUB
  • 13615 Views
  • 9 CrossRef citations
  • 0Altmetric

Explore articles

Explore the most recently published articles

Long-term results of the sequential combination of cladribine and rituximab in Hairy cell leukemia
Jennifer Marvin-Peek et al.
Article | Published online: 15 May 2024
Mitigating time toxicity in lymphoma and multiple myeloma
Mengyang Di et al.
Review Article | Published online: 15 May 2024
Pharmacokinetics of idelalisib in chronic lymphocytic leukemia and follicular lymphoma disclose better outcomes for patients with lower exposure
Fabien Despas et al.
Letter to the Editor | Published online: 15 May 2024
Prevalence and clinicopathological features of incidentally detected TRBC1-dim populations in peripheral blood flow cytometry
Paul Wadsworth et al.
Letter to the Editor | Published online: 15 May 2024
View all latest articles